Ad
related to: news fda
Search results
Nationwide water recall update as FDA issues level of concern
Newsweek· 2 days agoThe U.S. Food and Drug Administration (FDA) has issued an update regarding a previous recall for...
FDA prioritizes review of Jazz Pharmaceuticals' new cancer therapy By Investing.com
Investing.com· 3 hours agoJazz Pharmaceuticals (NASDAQ:JAZZ) announced that the U.S. Food and Drug Administration (FDA) has...
FDA fast tracks lung cancer treatment by Affimed By Investing.com
Investing.com· 3 hours agoThe U.S. Food and Drug Administration (FDA) has granted Fast Track designation to a novel lung...
FDA Establishes CDER Center for Clinical Trial Innovation (C3TI)
The National Law Review· 4 hours agoFood and Drug Administration FDA establishes Center for Drug Evaluation and Research CDER Center for...
FDA warns that nicotine-like chemicals in vapes may be more potent than nicotine
Fox News· 4 hours agoNicotine alternatives like 6-methyl nicotine in vapes may be more addictive than nicotine, according...
FDA sets review date for Merck's KEYTRUDA in mesothelioma treatment By Investing.com
Investing.com· 3 hours agoMerck & Co., Inc., a global healthcare leader, has announced that the U.S. Food and Drug...
Amgen Secures FDA Nod For Rare-Disease Treatment Biosimilar Based On AstraZeneca's Drug
Benzinga via Yahoo Finance· 2 hours agoTuesday, the FDA approved Amgen Inc (NASDAQ:AMGN) Bkemv (eculizumab-aeeb) as the first...
FDA urged to relax decades-old tissue donation restrictions for gay and bisexual men
Medical Xpress· 9 hours agoAdvocates, lawmakers, and groups focused on removing barriers to cornea donations, in particular,...
FDA Roundup: May 28, 2024
Clearfield Progress· 1 day agoOn Friday, the FDA announced it had opened a new period for applications for grants to support the development and potential approval or conditional approval of new animal ...
Milestone Pharma's NDA For Cardamyst Spray Gets FDA Acceptance, Shares Up
RTT News· 9 hours agoMilestone Pharmaceuticals Inc. (MIST) Wednesday announced that the FDA has accepted the Company's New Drug Application or NDA for Cardamyst nasal spray to manage paroxysmal supraventricular tachycardia or PSVT.
